Concepedia

Michelle Maynard

MM

Statistics

Publications

14

Citations

1.2K

H-Index

12

Active since

2005

Affiliations

University of Massachusetts Chan Medical School(Current)

Blueprint Medicines (United States)

Brigham and Women's Hospital

Oregon Health & Science University

Boston Children's Hospital

Michelle Maynard is an author at University of Massachusetts Chan Medical School specializing in medicine, cardiology, and molecular oncology.

Publications per year

2005–2024

14

Publications

14

Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven Cancers

Vivek Subbiah, Justin F. Gainor, Rami Rahal et al. · Cancer Discovery · 2018 · 393 citations

, , +17

Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2

Chad E. Darling, Rong Jiang, Michelle Maynard et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 199 citations

, , +13

Aging Mouse Hearts Are Refractory to Infarct Size Reduction With Post-Conditioning

Karin Przyklenk, Michelle Maynard, Chad E. Darling et al. · Journal of the American College of Cardiology · 2008 · 126 citations

, , +11

Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes

Karin Przyklenk, Michelle Maynard, Dale L. Greiner et al. · Antioxidants and Redox Signaling · 2010 · 123 citations

, , +14

DrugMap: A quantitative pan-cancer analysis of cysteine ligandability

Mariko Takahashi, Harrison B. Chong, Siwen Zhang et al. · Cell · 2024 · 93 citations · Full text

, , +13

1–5 of 14